Women in England and Wales denied exciting' drug that can stop breast cancer spreading
Briefly

from www.theguardian.com8 months ago
Results from the Destiny-Breast06 study show Enhertu can stall tumor growth by over a year, significantly longer than standard chemotherapy, reducing the risk of cancer progression by 38% in HER2-low breast cancer patients.
www.theguardian.comhttps://www.theguardian.com/society/article/2024/jun/03/women-in-england-and-wales-denied-exciting-drug-enhertu-that-can-stop-breast-cancer-spreading
Charities emphasize urgent need for Enhertu approval in England and Wales to prevent shortened lives; Dr. Vincent notes its potential for extending survival for HER2-low breast cancer patients who had chemotherapy.
www.theguardian.comhttps://www.theguardian.com/society/article/2024/jun/03/women-in-england-and-wales-denied-exciting-drug-enhertu-that-can-stop-breast-cancer-spreading
Read at www.theguardian.com
#enhertu #breast-cancer-treatment #access-to-medication #healthcare-regulations #clinical-study-results
[
|
]